欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/4250/004
药品名称Sunitinib Sandoz 50 mg, harde capsules
活性成分
    • SUNITINIB 50.0 mg
剂型Capsule, hard
上市许可持有人Sandoz B.V. Veluwezoom 22 Almere
参考成员国 - 产品名称Netherlands (NL)
Sunitinib Sandoz 50 mg, harde capsules RVG 122366
互认成员国 - 产品名称
    • Latvia (LV)
      Sunitinib Sandoz 50 mg cietās kapsulas
    • Hungary (HU)
      SZUNITINIB SANDOZ 50 mg kemény kapszula
    • Slovakia (SK)
      Sunitinib Sandoz 50 mg tvrdé kapsuly
    • Slovenia (SI)
      Sunitinib Sandoz 50 mg trde kapsule
    • Romania (RO)
    • Czechia (CZ)
      Sunitinib Sandoz
    • Cyprus (CY)
      Sunitinib Sandoz 50 mg
    • Bulgaria (BG)
      Sunitinib Sandoz
    • Estonia (EE)
      SUNITINIB SANDOZ
    • Lithuania (LT)
      Sunitinib Sandoz 50 mg kietosios kapsulės
    • Poland (PL)
      Sunitinib Sandoz
    • Finland (FI)
    • Norway (NO)
      Sunitinib Sandoz
    • Sweden (SE)
    • Greece (GR)
    • Portugal (PT)
    • France (FR)
    • Austria (AT)
      Sunitinib Sandoz 50 mg - Hartkapseln
    • Ireland (IE)
    • United Kingdom (Northern Ireland) (XI)
    • Belgium (BE)
      Sunitinib Sandoz 50 mg harde capsules
    • Denmark (DK)
    • Germany (DE)
    • Croatia (HR)
      Sunitinib Sandoz 50 mg tvrde kapsule
    • Malta (MT)
许可日期2019/02/27
最近更新日期2024/08/28
药物ATC编码
    • L01XE04 sunitinib
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase